Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Earnings
Panacea Life Sciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Panacea Life Sciences's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2019ended Sep 30, 2019 | Nov 14, 2019during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Panacea Life Sciences has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Panacea Life Sciences puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Panacea Life Sciences filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Update
- News
- Update
- Update
- Update
- News
- Update
- Update
- News
- News
See a number that looks wrong?